Update on neuropsychiatric symptoms of dementia: Evaluation and management

Geriatrics

Volumn 64, Issue 4, 2009, Pages 20-26

  Kalapatapu, Raj K ^a   Neugroschl, Judith A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Dementia; Evaluation; Management; Update

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CARBAMAZEPINE; CITALOPRAM; DIPHENHYDRAMINE; DONEPEZIL; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LITHIUM CARBONATE; MEDROXYPROGESTERONE; MEMANTINE; OXAZEPAM; RISPERIDONE; TRAZODONE; VALPROIC ACID;

AGED; AGITATION; ALZHEIMER DISEASE; ANAMNESIS; ANTICHOLINERGIC SYNDROME; ATAXIA; BEHAVIOR THERAPY; BLEEDING; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; BRADYCARDIA; CAREGIVER BURDEN; CLINICAL FEATURE; COGNITIVE THERAPY; CONFUSION; DELIRIUM; DETERIORATION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ERUPTION; DRUG INFORMATION; DRUG SAFETY; FALLING; FATIGUE; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; GERIATRIC PATIENT; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; HYPERAMMONEMIA; HYPONATREMIA; HYPOTENSION; INSOMNIA; INSTITUTIONALIZATION; KIDNEY FUNCTION; LIBIDO DISORDER; LIBODO; LIVER FUNCTION TEST; LIVER TOXICITY; LOW DRUG DOSE; MEDICAL EDUCATION; MUSIC THERAPY; NAUSEA; NURSING HOME PERSONNEL; ORTHOSTATIC HYPOTENSION; PATIENT ASSESSMENT; PATIENT CARE; PATIENT MONITORING; PATIENT SATISFACTION; PRIAPISM; QUALITY OF LIFE; REVIEW; SEDATION; SEROTONIN SYNDROME; SIDE EFFECT; SOMNOLENCE; STAFF TRAINING; THERAPY EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; VOMITING; XEROSTOMIA;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BEHAVIOR THERAPY; BENZODIAZEPINES; CHOLINESTERASE INHIBITORS; DEMENTIA; DOPAMINE AGENTS; GERIATRIC ASSESSMENT; HEALTH EDUCATION; HUMANS; LITHIUM CARBONATE; MEMANTINE;

EID: 65349096151     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Jeste DV, Blazer D, Casey D, et al. ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology. 2008;33:957-970.
2. Salzman C, Jeste DV, Meyer RE, et al. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry. 2008;69(6):889-898.
3. Rabins PV, et al. American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry. 2007;164(Suppl 12):5-56.
4. Phillips VL, Diwan S. The incremental effect of dementia-related problem behaviors on the time to nursing home placement in poor, frail, demented older people. J Am Geriatr Soc. 2003;51(2):188-193.
5. Pinquart M, Sörensen S. Differences between caregivers and noncaregivers in psychological health and physical health: a meta-analysis. Psychol Aging. 2003;18(2):250-267.
6. Lesser JM, Hughes S. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options. Geriatrics. 2006;61(2):14-20.
7. Cummings JL, Frank JC, Cherry D, et al. Guidelines for managing Alzheimer's disease: part I. Assessment. Am Fam Physician. 2002;65(ll):2263-2272.
8. Livingston G, Johnston K, Katona C, et al. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry. 2005;162(11):1996-2021.
9. Spector A, Thorgrimsen L, Woods B, et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial. Br J Psychiatry. 2003;183:248-254.
10. Ayalon L, Gum AM, Feliciano L, Areán PA. Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review. Arch Intern Med. 2006;166(20):2182-2188.
11. Ray WA, Taylor JA, Meador KG, et al. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education. Arch Intern Med. 1993;153(6):713-721.
12. Fossey J, Ballard C, Juszczak E, et al. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ. 2006;332(7544):756-761.
13. Zee RF, Burkett NR. Non-pharmacological and pharmacological treatment of the cognitive and behavioral symptoms of Alzheimer disease. NeuroRehabilitation. 2008;23(5):425-438.
14. MedicAlert + Safe Return. Alzheimer's Association Web site, http://www.alz.org/we-can-help-medicalert-safereturn.asp. Accessed 1/28/2009.
15. Atypical Antipsychotic Drugs Information. U.S. Food and Drug Administration Web site. http://www.fda.gov/CDER/drug/infopage/antipsychotics/ default.htm. Accessed1/23/2009.
16. Information on Antipsychotics. U.S. Food and Drug Administration Web site, http://www.fda.gov/CDER/drug/infopage/antipsychotics-con-ventional/ default.htm. Accessed 1/23/2009.
17. Pollock BG, Mulsant BH, Rosen J, et al. A double-blind comparison of citalopram and risperidone for treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry. 2007;15(ll):942-952.
18. Sommer BR, Fenn HH, Ketter TA. Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin. Expert Opin Drug Saf. 2007;6(2):133-145.
19. Kim Y, Wilkins KM, Tampi RR. Use of gaba-pen-tin in the treatment of behavioural and psychological symptoms of dementia: a review of the evidence. Drugs Aging. 2008;25(3):187-196.
20. Moretti R, Torre P, Antonello RM, et al. Gabapentin for treatment of behavioural alterations in dementia: preliminary 15-month investigation. Drugs Aging. 2003;20(14):1035-1040.
21. Hawkins JW, Tinklenberg JR, Sheikh Jl, Peyser CE, Yesavage JA. A retrospective chart review of gabapentin for treatment of aggressive and agitated behavior in patients with dementias. Am J Geriatr Psychiatry. 2000;8(3):221-225.
22. De Léon OA. Treatment of psychotic symptoms with lamotrigine in Alzheimer disease.J Clin Psychopharmacol. 2004;24(2):232-233.
23. Devarajan S, Dursun SM. Aggression in dementia with lamotrigine treatment. Am J Psychiatry. 2000;157(7):1178.
24. Konovalov S, Muralee S, Tampi RR. Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review. Int Psychogeriatr. 2008;20(2):293-308.
25. Ng B, Camacho A, Bardwell W, Sewell DD. Lamotrigine for agitation in older patients with dementia. Int Psychogeriatr. 2009;21(l):207-208.
26. Sajatovic M, Ramsay E, Nanry K, Thompson T. Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. Int J Geriatr Psychiatry. 2007;22(10):945-950.
27. Lamictal-Prescribing Information. GlaxoSmithKline Web site, http://us.gsk.com/products/assets/usjamictal.pdf. Accessed 1/29/2009.
28. Suicidal Behavior and Ideation and Antiepileptic Drugs. U.S. Food and Drug Administration Web site, http://www.fda.gov/cder/drug/infopage/ antiepileptics/default. htm. Accessed 1/26/2009.
29. Porsteinsson AP, Tariot PN, Erb R, et al. Placebo-controlled study of divalproex sodium for agitation in dementia. Am J Geriatr Psychiatry. 2001;9(l):58-66.
30. Sival RC, Haffmans PM, Jansen PA, Duursma SA, Eikelenboom P. Sodium valproate in the treatment of aggressive behavior in patients with dementia-a randomized placebo controlled clinical trial. Int J Geriatr Psychiatry. 2002;17(6):579-585.
31. Tariot PN, Raman R, Jakimovich L, et al. Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial. Am J Geriatr Psychiatry. 2005;13(ll):942-949.
32. Tariot PN, Erb R, Podgorski CA, et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry. 1998;155(1):54-61.
33. Olin JT, Fox LS, Pawluczyk S, Taggart NA, Schneider LS. A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease. Am J Geriatr Psychiatry. 2001;9(4):400-405.
34. Raina P, Santaguida P, Ismaila A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med. 2008;148(5):379-397.
35. Howard RJ, Juszczak E, Ballard CG, et al. Donepezil for the treatment of agitation in Alzheimer's disease. N Engl J Med. 2007;357(14):1382-1392.
36. Holmes C, Wilkinson D, Dean C, et al. The efficacy of donepezil in the treatment of neuropsychiatry symptoms in Alzheimer disease. Neurology. 2004;63(2):214-219.
37. Cummings JL, Mackell J, Kaufer D. Behavioral effects of current Alzheimer's disease treatments: a descriptive review. Alzheimers Dement. 2008;4(l):49-60.
38. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA. 2005;293(5):596-608.
39. Maidment ID, Fox CG, Boustani M, et al. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis. Ann Pharmacother. 2008;42(l):32-38.
40. Coccaro EF, Kramer E, Zemishlany Z, et al. Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients. Am J Psychiatry. 1990;147(12):1640-1645.